Report Detail
Global Biopharmaceutical CDMO Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4565370 |
- 07 November, 2023 |
- Global |
- 112 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Biopharmaceutical CDMO Service market size was valued at USD 15060 million in 2022 and is forecast to a readjusted size of USD 29010 million by 2029 with a CAGR of 9.8% during review period.
The Global Info Research report includes an overview of the development of the Biopharmaceutical CDMO Service industry chain, the market status of Pharmaceutical Company (Develop Innovative Drugs, Listed Patented Drug), Biotechnology Company (Develop Innovative Drugs, Listed Patented Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biopharmaceutical CDMO Service.
Regionally, the report analyzes the Biopharmaceutical CDMO Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biopharmaceutical CDMO Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biopharmaceutical CDMO Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biopharmaceutical CDMO Service industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Develop Innovative Drugs, Listed Patented Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biopharmaceutical CDMO Service market.
Regional Analysis: The report involves examining the Biopharmaceutical CDMO Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biopharmaceutical CDMO Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biopharmaceutical CDMO Service:
Company Analysis: Report covers individual Biopharmaceutical CDMO Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biopharmaceutical CDMO Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Biotechnology Company).
Technology Analysis: Report covers specific technologies relevant to Biopharmaceutical CDMO Service. It assesses the current state, advancements, and potential future developments in Biopharmaceutical CDMO Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biopharmaceutical CDMO Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biopharmaceutical CDMO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others
Market segment by Application
Pharmaceutical Company
Biotechnology Company
Others
Market segment by players, this report covers
KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biopharmaceutical CDMO Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biopharmaceutical CDMO Service, with revenue, gross margin and global market share of Biopharmaceutical CDMO Service from 2018 to 2023.
Chapter 3, the Biopharmaceutical CDMO Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biopharmaceutical CDMO Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceutical CDMO Service.
Chapter 13, to describe Biopharmaceutical CDMO Service research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Biopharmaceutical CDMO Service
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Biopharmaceutical CDMO Service by Type
- 1.3.1 Overview: Global Biopharmaceutical CDMO Service Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Biopharmaceutical CDMO Service Consumption Value Market Share by Type in 2022
- 1.3.3 Develop Innovative Drugs
- 1.3.4 Listed Patented Drug
- 1.3.5 Biosimilars
- 1.3.6 Others
- 1.4 Global Biopharmaceutical CDMO Service Market by Application
- 1.4.1 Overview: Global Biopharmaceutical CDMO Service Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Pharmaceutical Company
- 1.4.3 Biotechnology Company
- 1.4.4 Others
- 1.5 Global Biopharmaceutical CDMO Service Market Size & Forecast
- 1.6 Global Biopharmaceutical CDMO Service Market Size and Forecast by Region
- 1.6.1 Global Biopharmaceutical CDMO Service Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Biopharmaceutical CDMO Service Market Size by Region, (2018-2029)
- 1.6.3 North America Biopharmaceutical CDMO Service Market Size and Prospect (2018-2029)
- 1.6.4 Europe Biopharmaceutical CDMO Service Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Biopharmaceutical CDMO Service Market Size and Prospect (2018-2029)
- 1.6.6 South America Biopharmaceutical CDMO Service Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Biopharmaceutical CDMO Service Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 KBI Biopharma
- 2.1.1 KBI Biopharma Details
- 2.1.2 KBI Biopharma Major Business
- 2.1.3 KBI Biopharma Biopharmaceutical CDMO Service Product and Solutions
- 2.1.4 KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 KBI Biopharma Recent Developments and Future Plans
- 2.2 INCOG BioPharma Services
- 2.2.1 INCOG BioPharma Services Details
- 2.2.2 INCOG BioPharma Services Major Business
- 2.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Product and Solutions
- 2.2.4 INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 INCOG BioPharma Services Recent Developments and Future Plans
- 2.3 CordenPharma
- 2.3.1 CordenPharma Details
- 2.3.2 CordenPharma Major Business
- 2.3.3 CordenPharma Biopharmaceutical CDMO Service Product and Solutions
- 2.3.4 CordenPharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 CordenPharma Recent Developments and Future Plans
- 2.4 AGC Biologics
- 2.4.1 AGC Biologics Details
- 2.4.2 AGC Biologics Major Business
- 2.4.3 AGC Biologics Biopharmaceutical CDMO Service Product and Solutions
- 2.4.4 AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 AGC Biologics Recent Developments and Future Plans
- 2.5 Northway Biotech
- 2.5.1 Northway Biotech Details
- 2.5.2 Northway Biotech Major Business
- 2.5.3 Northway Biotech Biopharmaceutical CDMO Service Product and Solutions
- 2.5.4 Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Northway Biotech Recent Developments and Future Plans
- 2.6 PlantForm Corp
- 2.6.1 PlantForm Corp Details
- 2.6.2 PlantForm Corp Major Business
- 2.6.3 PlantForm Corp Biopharmaceutical CDMO Service Product and Solutions
- 2.6.4 PlantForm Corp Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 PlantForm Corp Recent Developments and Future Plans
- 2.7 Lonza
- 2.7.1 Lonza Details
- 2.7.2 Lonza Major Business
- 2.7.3 Lonza Biopharmaceutical CDMO Service Product and Solutions
- 2.7.4 Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Lonza Recent Developments and Future Plans
- 2.8 ADL Biopharma
- 2.8.1 ADL Biopharma Details
- 2.8.2 ADL Biopharma Major Business
- 2.8.3 ADL Biopharma Biopharmaceutical CDMO Service Product and Solutions
- 2.8.4 ADL Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 ADL Biopharma Recent Developments and Future Plans
- 2.9 Catalent
- 2.9.1 Catalent Details
- 2.9.2 Catalent Major Business
- 2.9.3 Catalent Biopharmaceutical CDMO Service Product and Solutions
- 2.9.4 Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Catalent Recent Developments and Future Plans
- 2.10 Future Fields
- 2.10.1 Future Fields Details
- 2.10.2 Future Fields Major Business
- 2.10.3 Future Fields Biopharmaceutical CDMO Service Product and Solutions
- 2.10.4 Future Fields Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Future Fields Recent Developments and Future Plans
- 2.11 Vetter Pharma
- 2.11.1 Vetter Pharma Details
- 2.11.2 Vetter Pharma Major Business
- 2.11.3 Vetter Pharma Biopharmaceutical CDMO Service Product and Solutions
- 2.11.4 Vetter Pharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Vetter Pharma Recent Developments and Future Plans
- 2.12 Stelis
- 2.12.1 Stelis Details
- 2.12.2 Stelis Major Business
- 2.12.3 Stelis Biopharmaceutical CDMO Service Product and Solutions
- 2.12.4 Stelis Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Stelis Recent Developments and Future Plans
- 2.13 Richter-Helm
- 2.13.1 Richter-Helm Details
- 2.13.2 Richter-Helm Major Business
- 2.13.3 Richter-Helm Biopharmaceutical CDMO Service Product and Solutions
- 2.13.4 Richter-Helm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Richter-Helm Recent Developments and Future Plans
- 2.14 FUJIFILM Diosynth Biotechnologies
- 2.14.1 FUJIFILM Diosynth Biotechnologies Details
- 2.14.2 FUJIFILM Diosynth Biotechnologies Major Business
- 2.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product and Solutions
- 2.14.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
- 2.15 Cambrex
- 2.15.1 Cambrex Details
- 2.15.2 Cambrex Major Business
- 2.15.3 Cambrex Biopharmaceutical CDMO Service Product and Solutions
- 2.15.4 Cambrex Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.15.5 Cambrex Recent Developments and Future Plans
- 2.16 Pfizer CentreOne
- 2.16.1 Pfizer CentreOne Details
- 2.16.2 Pfizer CentreOne Major Business
- 2.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Product and Solutions
- 2.16.4 Pfizer CentreOne Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.16.5 Pfizer CentreOne Recent Developments and Future Plans
- 2.17 Samsung Biologics
- 2.17.1 Samsung Biologics Details
- 2.17.2 Samsung Biologics Major Business
- 2.17.3 Samsung Biologics Biopharmaceutical CDMO Service Product and Solutions
- 2.17.4 Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.17.5 Samsung Biologics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Biopharmaceutical CDMO Service Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Biopharmaceutical CDMO Service by Company Revenue
- 3.2.2 Top 3 Biopharmaceutical CDMO Service Players Market Share in 2022
- 3.2.3 Top 6 Biopharmaceutical CDMO Service Players Market Share in 2022
- 3.3 Biopharmaceutical CDMO Service Market: Overall Company Footprint Analysis
- 3.3.1 Biopharmaceutical CDMO Service Market: Region Footprint
- 3.3.2 Biopharmaceutical CDMO Service Market: Company Product Type Footprint
- 3.3.3 Biopharmaceutical CDMO Service Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Biopharmaceutical CDMO Service Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Biopharmaceutical CDMO Service Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Biopharmaceutical CDMO Service Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Biopharmaceutical CDMO Service Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Biopharmaceutical CDMO Service Consumption Value by Type (2018-2029)
- 6.2 North America Biopharmaceutical CDMO Service Consumption Value by Application (2018-2029)
- 6.3 North America Biopharmaceutical CDMO Service Market Size by Country
- 6.3.1 North America Biopharmaceutical CDMO Service Consumption Value by Country (2018-2029)
- 6.3.2 United States Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 6.3.3 Canada Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Biopharmaceutical CDMO Service Consumption Value by Type (2018-2029)
- 7.2 Europe Biopharmaceutical CDMO Service Consumption Value by Application (2018-2029)
- 7.3 Europe Biopharmaceutical CDMO Service Market Size by Country
- 7.3.1 Europe Biopharmaceutical CDMO Service Consumption Value by Country (2018-2029)
- 7.3.2 Germany Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 7.3.3 France Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 7.3.5 Russia Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 7.3.6 Italy Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Biopharmaceutical CDMO Service Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Biopharmaceutical CDMO Service Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Biopharmaceutical CDMO Service Market Size by Region
- 8.3.1 Asia-Pacific Biopharmaceutical CDMO Service Consumption Value by Region (2018-2029)
- 8.3.2 China Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 8.3.3 Japan Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 8.3.5 India Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 8.3.7 Australia Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Biopharmaceutical CDMO Service Consumption Value by Type (2018-2029)
- 9.2 South America Biopharmaceutical CDMO Service Consumption Value by Application (2018-2029)
- 9.3 South America Biopharmaceutical CDMO Service Market Size by Country
- 9.3.1 South America Biopharmaceutical CDMO Service Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Biopharmaceutical CDMO Service Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Biopharmaceutical CDMO Service Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Country
- 10.3.1 Middle East & Africa Biopharmaceutical CDMO Service Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
- 10.3.4 UAE Biopharmaceutical CDMO Service Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Biopharmaceutical CDMO Service Market Drivers
- 11.2 Biopharmaceutical CDMO Service Market Restraints
- 11.3 Biopharmaceutical CDMO Service Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Biopharmaceutical CDMO Service Industry Chain
- 12.2 Biopharmaceutical CDMO Service Upstream Analysis
- 12.3 Biopharmaceutical CDMO Service Midstream Analysis
- 12.4 Biopharmaceutical CDMO Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Biopharmaceutical CDMO Service. Industry analysis & Market Report on Biopharmaceutical CDMO Service is a syndicated market report, published as Global Biopharmaceutical CDMO Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Biopharmaceutical CDMO Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
